Clinical Research Directory

Inclusion Criteria: * Adult individuals \> 18 years of age. * Able and willing to provide informed/signed consent. * Presence of HIV-1 infection as documented by a licensed ELISA test kit and confirmed by Western blot or HIV RNA. * Current antiretroviral therapy, Genvoya or Stribild for HIV-1 infection. * At least 1 or more concurrent prescription medication. * HIV VL \< 50 for over 6 months, no current OI, no cancers Exclusion Criteria: * Use of drugs of abuse or alcohol which would interfere with adherence or completion of this study. * Current antiretroviral therapy other than GenvoyaTM or StribildTM for HIV-1 infection. * Pregnancy or breast-feeding. Women of childbearing potential must have a negative serum or urine pregnancy test within 14 days prior to study entry and day of entry. * Chronic, severe, or other medical conditions that, in the opinion of the investigator, would interfere with the subject's ability to participate in the protocol. * Use of prohibited protocol-specified drugs, prescription or over-the-counter medication (see Section 6.4.2) within 14 days prior to study entry. * Moderate or severe cognitive impairment by history that, in the opinion of the investigator, would interfere with the subject's ability to participate in the protocol * Laboratory parameters documented within 21 days prior to study entry that would increase the risk for adverse events: 1. Hemoglobin \< 12.5 g/dL for men; \< 11.5 g/dL for women; 2. Platelet count \< 100,000 platelets/mm 3; 3. AST (SGOT) or ALT (SGPT) \> 1.5 x the upper limit of normal (ULN); 4. Estimated GFR \< 30 ml/min